MedPath

Evaluation of efficacy and safety of perampanel in post-operative glioma patients with epilepsy

Not Applicable
Conditions
glioma
Registration Number
JPRN-UMIN000026095
Lead Sponsor
Kindai University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

1)patients with contraindication of perampanel or levetiracetam 2)inadequate patient judged by the investigator 3)pregnant woman

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath